OICR NEWS

OICR News

OICR accelerates cancer research to produce better health in the province. We do this by supporting talent, technology, commercialization and collaboration.

Filters

Discover the latest news and insightsDiscover the latest news and insights

All Collaboration Commercialization Talent Technology

All Video Article

Clear all filters

Filtered stories

Showing: Commercialization

Commercialization

Ontario commercialization partnership fills critical gap for women entrepreneurs and advances cancer discoveries

The WeSEED program from FACIT and OBIO® provides support and seed investment for women-led life sciences companies. Two of Ontario’s leading drivers of life sciences innovation have teamed up to empower the province’s women entrepreneurs,…

ArticleAug 19, 2026

CommercializationDiagnosis

Critical lung cancer staging streamlined by AI in FACIT Falcons’ Fortunes winning tech

Dr. Waël Hanna of NodeAI Diagnostics took home the $100,000 Ernsting Entrepreneurship Award for his innovative technology to improve lymph node biopsies. Knowing whether lung cancer has spread to the lymph nodes is essential to…

ArticleApr 30, 2025

CommercializationTreatment

New patient-centred system for brain cancer radiotherapy receives top honours at FACIT Falcons’ Fortunes

Dr. Hatim Fakir of London Health Sciences Centre won the 2024 pitch competition for his RadioSphere technology. As a Medical Physicist, Dr. Hatim Fakir has seen first-hand how difficult radiosurgery can be for patients with…

ArticleJun 26, 2024

Commercialization

OICR-supported cancer therapeutics company Fusion Pharmaceuticals acquired by AstraZeneca for up to US $2.4 billion

This landmark acquisition of the Hamilton-based company comes after years of funding and support from OICR and FACIT. AstraZeneca’s acquisition of Hamilton-based Fusion Pharmaceuticals for up to US $2.4 billion marks a major milestone for…

ArticleMar 25, 2024

Commercialization

New tech could modernize recovery from gynecological cancers

With support from FACIT, Hyivy Health aims to improve pelvic rehabilitation with a new, patient-centred device. It was painfully obvious to Rachel Bartholomew back in 2019 that women’s pelvic rehabilitation needed to be brought into…

ArticleDec 19, 2023

CommercializationDiagnosis

Wave of medical imaging innovation hits shores of Lake Superior

Collaboration with OICR and capital from FACIT contributing to a growing hub of medical imaging research in Thunder Bay. When Sasha Bubon arrived in Thunder Bay in January 2010 to begin his master’s studies in…

ArticleSep 27, 2023

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

OICR News

Discover the latest news and insightsDiscover the latest news and insights

Filtered stories

Ontario commercialization partnership fills critical gap for women entrepreneurs and advances cancer discoveries

Critical lung cancer staging streamlined by AI in FACIT Falcons’ Fortunes winning tech

New patient-centred system for brain cancer radiotherapy receives top honours at FACIT Falcons’ Fortunes

Cancer solved together — in your inbox

OICR-supported cancer therapeutics company Fusion Pharmaceuticals acquired by AstraZeneca for up to US $2.4 billion

New tech could modernize recovery from gynecological cancers

Wave of medical imaging innovation hits shores of Lake Superior